United States Neuropathic Pain Market Share 2025 | Leading Players & Emerging Treatment Paths - Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal

Neuropathic Pain Market reached US$ 8.44 Billion in 2024 and is expected to reach US$ 18.45 Billion by 2033, growing at a CAGR of 8.9 % during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Neuropathic Pain Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/neuropathic-pain-market?kb

Key Players:

Pfizer Inc., AdvaCare Pharma, Eli Lilly and Company., Vertex Pharmaceuticals, Abbott, Medtronic, Nevro Corp., Grünenthal, Teva Pharmaceuticals Inc., and Sun Pharmaceutical Industries Ltd

Key Development:

In November 2024, Grünenthal announced that its U.S. subsidiary, Averitas Pharma, successfully completed patient enrollment for the Phase III AV001 trial. The study aims to assess the efficacy, safety, and tolerability of the QUTENZA (capsaicin) 8% topical system for post-surgical neuropathic pain (PSNP). Positive outcomes could pave the way for a U.S. label expansion for QUTENZA.

Growth Forecast Projected:

The Global Neuropathic Pain Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Neuropathic Pain Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports) @: https://www.datamintelligence.com/buy-now-page?report=neuropathic-pain-market?kb

Key Segments:

By Type: Diabetic Neuropathy, Chemotherapy-Induced Peripheral Neuropathy, Post-Herpetic Neuralgia, Trigeminal Neuralgia, Spinal Stenosis, Others

By Treatment Type: Drug Class, Anticonvulsants, Tricyclic Antidepressants (TCAs), Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs), Opioids, Capsaicin Cream, Local Anesthetics, Steroids, Others, Devices

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Neuropathic Pain producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Neuropathic Pain revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/neuropathic-pain-market?kb

FAQ's

Q1: What is the current size of the Neuropathic Pain Market?

A: The Neuropathic Pain Market stood at US$ 8.44 Billion in 2024 and is set to experience remarkable growth, reaching US$ 18.45 Billion by 2033

Q2: How fast is the Neuropathic Pain Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 8.9 % from 2025 to 2032

Get 2-Day Free Trial + 50% OFF DataM Subscription@: https://www.datamintelligence.com/reports-subscription?kb

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.